Sonnet BioTherapeutics Holdings, Inc. Quarterly Common Stock, Shares, Issued from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Sonnet BioTherapeutics Holdings, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2010 to Q2 2024.
  • Sonnet BioTherapeutics Holdings, Inc. Common Stock, Shares, Issued for the quarter ending June 30, 2024 was 5.22M shares, a 86.4% decline year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 5.22M -33.2M -86.4% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 3.11M -17.4M -84.8% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 3.07M -4.89M -61.5% Dec 31, 2023 10-Q 2024-02-14
Q3 2023 1.75M +1.5M +595% Sep 30, 2023 10-Q 2024-08-14
Q2 2023 38.4M -22.2M -36.6% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 20.5M -39.8M -66% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 7.96M -52.3M -86.8% Dec 31, 2022 10-Q 2023-02-13
Q3 2022 252K -4.05M -94.1% Sep 30, 2022 10-K 2023-12-14
Q2 2022 60.6M +35.8M +145% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 60.3M +39.1M +184% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 60.3M +43.1M +251% Dec 31, 2021 10-Q 2022-02-08
Q3 2021 4.3M -10.4M -70.8% Sep 30, 2021 10-K 2022-12-15
Q2 2021 24.8M +15.6M +169% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 21.2M +20.6M +3759% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 17.2M +16.8M +4192% Dec 31, 2020 10-Q 2021-02-16
Q3 2020 14.7M +9.18M +165% Sep 30, 2020 10-K 2021-12-17
Q2 2020 9.2M +2.19M +31.2% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 549K -3.18M -85.3% Mar 31, 2020 10-Q 2020-05-18
Q4 2019 400K -3.32M -89.2% Dec 31, 2019 10-Q 2020-05-18
Q3 2019 5.55M +1.84M +49.7% Sep 30, 2019 10-K 2020-12-17
Q2 2019 7.01M +3.31M +89.6% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 3.73M +510K +15.8% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 3.72M +670K +22% Dec 31, 2018 10-K 2020-03-19
Q3 2018 3.71M +1.19M +47.4% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 3.7M +1.2M +47.9% Jun 30, 2018 10-Q 2018-08-13
Q1 2018 3.22M -18.9M -85.5% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 3.05M +906K +42.4% Dec 31, 2017 10-K 2019-04-01
Q3 2017 2.51M -19.4M -88.6% Sep 30, 2017 10-Q 2017-11-13
Q2 2017 2.5M -19.5M -88.6% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 22.1M +812K +3.81% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 2.14M -19.2M -90% Dec 31, 2016 10-K 2018-03-30
Q3 2016 22M +628K +2.95% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 22M +8.28M +60.5% Jun 30, 2016 10-Q 2016-08-11
Q1 2016 21.3M +9.03M +73.4% Mar 31, 2016 10-Q 2016-05-16
Q4 2015 21.3M +14.1M +194% Dec 31, 2015 10-K 2017-03-31
Q3 2015 21.3M +14.4M +206% Sep 30, 2015 10-Q 2015-11-16
Q2 2015 13.7M +7.18M +111% Jun 30, 2015 10-Q 2015-08-14
Q1 2015 12.3M +5.98M +94.7% Mar 31, 2015 10-Q 2015-05-20
Q4 2014 7.25M +1.86M +34.6% Dec 31, 2014 10-K 2016-03-31
Q3 2014 6.98M +2.51M +56.2% Sep 30, 2014 10-Q 2014-11-14
Q2 2014 6.5M +2.8M +75.5% Jun 30, 2014 10-Q 2014-08-14
Q1 2014 6.32M +2.62M +70.9% Mar 31, 2014 10-Q 2014-05-15
Q4 2013 5.39M +1.69M +45.7% Dec 31, 2013 10-K 2015-04-15
Q3 2013 4.47M +769K +20.8% Sep 30, 2013 10-Q 2013-11-15
Q2 2013 3.7M -253K -6.39% Jun 30, 2013 10-Q 2013-08-12
Q1 2013 3.7M +687K +22.8% Mar 31, 2013 10-Q 2013-05-15
Q4 2012 3.7M +2.19M +146% Dec 31, 2012 10-K 2014-03-31
Q3 2012 3.7M +687K +22.8% Sep 30, 2012 10-Q/A 2012-12-31
Q2 2012 3.96M +971K +32.5% Jun 30, 2012 10-Q/A 2013-01-02
Q1 2012 3.01M Mar 31, 2012 10-Q/A 2012-12-28
Q4 2011 1.51M -1.07M -41.4% Dec 31, 2011 10-K 2013-04-03
Q3 2011 3.01M Sep 30, 2011 10-Q 2011-11-14
Q2 2011 2.98M Jun 30, 2011 10-Q 2011-08-15
Q4 2010 2.57M Dec 31, 2010 10-K/A 2012-12-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.